NEWS IN BRIEF

Viva 5 licenses NUtech Ventures’ probiotic for new synbiotic product

By Adi Menayang contact

- Last updated on GMT

iStock / frentusha
iStock / frentusha
Viva 5 will be the exclusive worldwide distributor of a new synbiotic ingredient—a combination of probiotic and prebiotic—after signing a licensing agreement with NUtech Ventures, the technology commercialization affiliate for the University of Nebraska-Lincoln.

The newly licensed, patent-pending probiotic is Bifidobacterium adolescentis ​IVS-1, isolated via a novel prebiotic enrichment strategy known as In Vivo Selection ​(hence the IVS). The synbiotic was formulated by researchers at University of Nebraska-Lincoln.

It is being commercialized by NUTech Ventures​, an intellectual property and commercialization unit of the university with a mission to facilitate the commercial and practical use of innovations generated through the university’s research activities.

The synbiotic is a combination of the Bifidobacterium adolescentis ​IVS-1 with a galactooligosaccharide prebiotic.

“Most, if not all, of the synbiotics on the market have not been rationally formulated based on ecological criteria. They have been combined based on cost, marketing, or limited or no scientific studies showing evidence for synergistic or additive effects,” ​said Albert Dahbour, executive vice president at Viva 5 Corporation​.

“In a true synbiotic, the prebiotic should have high affinity for the probiotic, it should selectively support growth of the probiotic in the human intestinal tract and, ultimately, show a health benefit to the host. Thus, Viva 5 now has in our opinion the first real synbiotic and we are looking to further invest in additional research.”

Viva 5 Corporation’s newly licensed synbiotic will be available in capsule, tablet, stick pack, and powder delivery forms and can be utilized as a stand-alone product or combined with other compatible ingredients.

Related news

Show more

Related products

show more

B. breve B-3 – the weight management probiotics

B. breve B-3 – the weight management probiotics

Morinaga Milk Industry Co., Ltd. | 20-Nov-2019 | Clinical Study

Morinaga Milk’s Human-Residential Bifidobacteria (HRB) probiotics possess superior physiological benefits and are typically well-suited for human consumption....

HRB are ideal probiotics for human health

HRB are ideal probiotics for human health

Morinaga Milk Industry Co., Ltd. | 20-Nov-2019 | Technical / White Paper

Evidence is accumulated that the physiological benefits of probiotics bifidobacteria are not only strain-specific but also dependent on their residential...

Celery Juice and the Health-Conscious Consumer

Celery Juice and the Health-Conscious Consumer

Florida Food Products | 21-Oct-2019 | Technical / White Paper

Celery juice is an on-trend beverage ingredient with sought-after health benefits. Given its popularity, it’s no surprise that celery juice is showing...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars